FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074182194> ?p ?o ?g. }

• W2074182194 abstract "Introduction There are numerous causes triggering CRC. 25-80% of CRC shown a deregulation in Epidermal Growth Factor Receptor (EGFR) pathway. Two signaling pathways downstream of the EGFR are dysregulated in CRC the mitogen-activated protein kinase (MAPK) and the phosphoinositide-3-kinase (PI3K) pathway. Activating mutations in KRAS and BRAF (MAPK pathway) and PIK3CA affect prognosis and/or response to anti-EGFR MoAb. PTEN is a downstream effector of EGFR pathway and is involved in PI3K pathway. Loss of PTEN protein expression can occur through epigenetic silencing and mutation or allelic loss. Immunohistochemistry (IHC) is the most effective way to assay for loss of PTEN expression. IHC lack of reproducibility and this has lead to discordant results regarding the concordant in paired CRC metastases and primary tumors.The aim of the work was to asses the feasibility of PTEN gene expression analysis from FFPE tissue in CRC samples. Materials and methods We selected a series of 33 patients, already tested for KRAS mutational status and resulted wild-type. At the time of the study mutational status of NRAS gene has not a role as predictive marker, so was not performed. A retrospective analysis on CRC FFPE tissue was performed. As control samples we have selected specimen of colorectal surgery not tumor-associated (diverticulitis). On these samples BRAF mutational analysis and PTEN gene expression was performed. For BRAF analysis, DNA was extracted by means of QIAamp DNA FFPE tissue kit (Qiagen, USA). BRAF mutational status was assed through direct automated sequencing (3100 Genetic Analyzer, Applied Biosystems) and TaqMan mutation detection assay (ABI PRIM 7900HT, Applied Biosystems). For PTEN gene expression, total RNA was obtained through the miRNeasy FFPE tissue kit (Qiagen, USA), according to manufacturer instructions, and reverse transcribed. PTEN expression was assessed by means of TaqMan probes. Results According to BRAF mutational status we have found 10/33 (30%) mutated samples. PTEN expression levels were evaluated by the comparison of tumor samples vs diverticula samples, the data obtained were then integrated with those from BRAF mutational analysis. Interestingly we found that all the BRAF mutated samples present also a down-regulation of PTEN. Statistical analyses were conducted through the X 2 test with the Yatesha correction (p=0.00023). The p-value was also calculated Exact Fisher Test (p= 0.00021) to confirm the results. Conclusion The determination of PTEN gene expression level is feasible with real-time PCR using TaqMan probe technology. BRAF analysis might be used as prognostic and/or predictive marker in CRC patients’ treatment. The identification of a validated method for PTEN analysis would establish it as a molecular marker meriting further investigation in large numbers of available primary tumors from patients with CRC. Further analyses are requested to confirm these data. Citation Format: Christian D. Rolfo, Marta Castiglia, Daniela Cabibi, Valentina Calo9, Florinda Di Piazza, Viviana Bazan, Fabio Brocco, Stefano Caruso, Loredana Bruno, Konstantinos Papadimitriou, Francesco Passiglia, Marc Peeters, Patrick Pauwels, Antonio Russo. Molecular analysis of BRAF gene and PTEN gene expression in metastatic colorectal cancer patients: Feasibility study. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 448. doi:10.1158/1538-7445.AM2014-448" @default.
• W2074182194 created "2016-06-24" @default.
• W2074182194 creator A5000995161 @default.
• W2074182194 creator A5004417280 @default.
• W2074182194 creator A5010187100 @default.
• W2074182194 creator A5017866134 @default.
• W2074182194 creator A5026050980 @default.
• W2074182194 creator A5033609878 @default.
• W2074182194 creator A5056727791 @default.
• W2074182194 creator A5065656598 @default.
• W2074182194 creator A5069521698 @default.
• W2074182194 creator A5074506844 @default.
• W2074182194 creator A5078108736 @default.
• W2074182194 creator A5079185525 @default.
• W2074182194 creator A5085742130 @default.
• W2074182194 creator A5088839352 @default.
• W2074182194 date "2014-09-30" @default.
• W2074182194 modified "2023-10-16" @default.
• W2074182194 title "Abstract 448: Molecular analysis ofBRAFgene andPTENgene expression in metastatic colorectal cancer patients: Feasibility study" @default.
• W2074182194 doi "https://doi.org/10.1158/1538-7445.am2014-448" @default.
• W2074182194 hasPublicationYear "2014" @default.
• W2074182194 type Work @default.
• W2074182194 sameAs 2074182194 @default.
• W2074182194 citedByCount "0" @default.
• W2074182194 crossrefType "proceedings-article" @default.
• W2074182194 hasAuthorship W2074182194A5000995161 @default.
• W2074182194 hasAuthorship W2074182194A5004417280 @default.
• W2074182194 hasAuthorship W2074182194A5010187100 @default.
• W2074182194 hasAuthorship W2074182194A5017866134 @default.
• W2074182194 hasAuthorship W2074182194A5026050980 @default.
• W2074182194 hasAuthorship W2074182194A5033609878 @default.
• W2074182194 hasAuthorship W2074182194A5056727791 @default.
• W2074182194 hasAuthorship W2074182194A5065656598 @default.
• W2074182194 hasAuthorship W2074182194A5069521698 @default.
• W2074182194 hasAuthorship W2074182194A5074506844 @default.
• W2074182194 hasAuthorship W2074182194A5078108736 @default.
• W2074182194 hasAuthorship W2074182194A5079185525 @default.
• W2074182194 hasAuthorship W2074182194A5085742130 @default.
• W2074182194 hasAuthorship W2074182194A5088839352 @default.
• W2074182194 hasConcept C104317684 @default.
• W2074182194 hasConcept C119056186 @default.
• W2074182194 hasConcept C121608353 @default.
• W2074182194 hasConcept C126322002 @default.
• W2074182194 hasConcept C21790070 @default.
• W2074182194 hasConcept C2777609662 @default.
• W2074182194 hasConcept C2781187634 @default.
• W2074182194 hasConcept C502942594 @default.
• W2074182194 hasConcept C526805850 @default.
• W2074182194 hasConcept C54355233 @default.
• W2074182194 hasConcept C62478195 @default.
• W2074182194 hasConcept C71924100 @default.
• W2074182194 hasConcept C86554907 @default.
• W2074182194 hasConcept C86803240 @default.
• W2074182194 hasConceptScore W2074182194C104317684 @default.
• W2074182194 hasConceptScore W2074182194C119056186 @default.
• W2074182194 hasConceptScore W2074182194C121608353 @default.
• W2074182194 hasConceptScore W2074182194C126322002 @default.
• W2074182194 hasConceptScore W2074182194C21790070 @default.
• W2074182194 hasConceptScore W2074182194C2777609662 @default.
• W2074182194 hasConceptScore W2074182194C2781187634 @default.
• W2074182194 hasConceptScore W2074182194C502942594 @default.
• W2074182194 hasConceptScore W2074182194C526805850 @default.
• W2074182194 hasConceptScore W2074182194C54355233 @default.
• W2074182194 hasConceptScore W2074182194C62478195 @default.
• W2074182194 hasConceptScore W2074182194C71924100 @default.
• W2074182194 hasConceptScore W2074182194C86554907 @default.
• W2074182194 hasConceptScore W2074182194C86803240 @default.
• W2074182194 hasLocation W20741821941 @default.
• W2074182194 hasOpenAccess W2074182194 @default.
• W2074182194 hasPrimaryLocation W20741821941 @default.
• W2074182194 hasRelatedWork W2008373148 @default.
• W2074182194 hasRelatedWork W2027537860 @default.
• W2074182194 hasRelatedWork W2048639573 @default.
• W2074182194 hasRelatedWork W2112429053 @default.
• W2074182194 hasRelatedWork W2136208806 @default.
• W2074182194 hasRelatedWork W2162886392 @default.
• W2074182194 hasRelatedWork W2173647718 @default.
• W2074182194 hasRelatedWork W2313819191 @default.
• W2074182194 hasRelatedWork W2324687807 @default.
• W2074182194 hasRelatedWork W2325361197 @default.
• W2074182194 hasRelatedWork W2332341885 @default.
• W2074182194 hasRelatedWork W2409409600 @default.
• W2074182194 hasRelatedWork W2529799985 @default.
• W2074182194 hasRelatedWork W2564162469 @default.
• W2074182194 hasRelatedWork W2885237503 @default.
• W2074182194 hasRelatedWork W2887025041 @default.
• W2074182194 hasRelatedWork W2906962335 @default.
• W2074182194 hasRelatedWork W2921014868 @default.
• W2074182194 hasRelatedWork W3007611542 @default.
• W2074182194 hasRelatedWork W3208257519 @default.
• W2074182194 isParatext "false" @default.
• W2074182194 isRetracted "false" @default.
• W2074182194 magId "2074182194" @default.
• W2074182194 workType "article" @default.